Respiratory Syncytial Virus (RSV) Therapeutics Market Trends and Overview The market size of Respiratory Syncytial Virus (RSV) Therapeutics was recorded at USD 1040.65 Million in 2022. It is projected to witness substantial growth and reach USD 9080.84 Million by 2030, exhibiting a remarkable compound annual growth rate (CAGR) of 31.1% during the forecast period from 2023 to 2030. The...